Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Vorinostat and bevacizumab for recurrent glioblastoma

Vorinostat and bevacizumab for recurrent glioblastoma

FromNeuro-Oncology: The Podcast


Vorinostat and bevacizumab for recurrent glioblastoma

FromNeuro-Oncology: The Podcast

ratings:
Length:
33 minutes
Released:
Jan 1, 2021
Format:
Podcast episode

Description

Dr. Iyad Alnahhas interviews Drs. Vinay Puduvalli and Ying Yuan about their paper "A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma" published in Neuro-Oncology in March 2020
Released:
Jan 1, 2021
Format:
Podcast episode

Titles in the series (79)

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.